Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities-Reference-Cited by-同舟云学术

Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities

Published:2017-02-20 Issue:4 Volume:16 Page:377-390
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Dasari Vijayendra¹,Bhatt Kunal H.¹,Smith Corey¹,Khanna Rajiv¹

Affiliation:

1. QIMR Centre for Immunotherapy and Vaccine Development and Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Australia

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2017.1293529

Reference155 articles.

1. Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

2. Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

3. Behavioral, Virologic, and Immunologic Factors Associated With Acquisition and Severity of Primary Epstein–Barr Virus Infection in University Students

4. Epstein–barr virus vaccines

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infectious Mononucleosis: An Updated Review;Current Pediatric Reviews;2024-08

2. КЛІНІЧНИЙ ПЕРЕБІГ ХРОНІЧНОЇ ЕПШТЕЙНА-БАРР ВІРУСНОЇ ІНФЕКЦІЇ У ДІТЕЙ ДОШКІЛЬНОГО ВІКУ;Інфекційні хвороби;2024-02-09

3. Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development;Health Science Reports;2024-02

4. Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice;Nature Communications;2023-08-08

5. Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma;Scientific Reports;2023-04-18